compounded semaglutide medicines Compound versions of GLP-1 drugs for weight loss halted by FDA Semaglutide for Weight Loss |

Currently, there is no official FDA indication for GLP-1 receptor agonists specifically targeting inflammation, and clinical guidelines do not recommend this approach outside established indications

Early studies discovered a reduced incretin effect in individuals with type 2 diabetes following oral glucose intake 16,17,18

Even when not breastfeeding, people who take GLP-1s are more likely to become nutrient deficient

But that headline masks a steep cost gradient

Track your transformation with your personal Journey Card to document every milestone

This pattern is very reminiscent of other chronic conditions when patients go off their medications or fall out of care